Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands

by Carin A. Uyl-de Groot, Elisabeth M. van Rooijen, Cornelis J. A. Punt, Chris P. Pescott
Published 2018-07-01